At the moment, the period that elapses between the filing of an application for a patent for a new medicinal product and authorisation to place the medicinal product on the market makes the period of effective protection under the patent insufficient to cover the investment put into the research.
Recital 4, Regulation (EC) No 469/2009 of the European Parliament and of the Council of 6 May 2009…
The 10 that are cited most themselves, of 26.
Judgment of the Court (Fourth Chamber) of 24 November 2011. Medeva BV v Comptroller General of Patents, Designs and Trade Marks.Decision
Recital 1 and recitals 4 to 10 in the preamble to Regulation No 469/2009 are worded as follows: ‘(1) Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal …
24 Nov 2011 · 62010CJ0322
Judgment of the Court (Fourth Chamber) of 24 November 2011. Georgetown University and Others v Comptroller General of Patents, Designs and TDecision
Recital 1 and recitals 4 to 10 in the preamble to Regulation No 469/2009 are worded as follows: Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products …
24 Nov 2011 · 62010CJ0422
Judgment of the Court (Third Chamber), 12 December 2013. Actavis Group PTC EHF and Actavis UK Ltd v Sanofi.Decision
Recitals 4, 5, 9 and 10 in the preamble to Regulation No 469/2009 read as follows: At the moment, the period that elapses between the filing of an application for a patent for a new medicinal product and authorisation to place the …
12 Dec 2013 · 62012CJ0443
Judgment of the Court (Fourth Chamber), 19 July 2012. Neurim Pharmaceuticals (1991) Ltd v Comptroller-General of Patents.Decision
Recitals 1 and 4 to 10 of the SPC Regulation read as follows: Council Regulation (EEC) No 1768/92 … has been substantially amended several times. In the interests of clarity and rationality the said Regulation should be codified. ... At …
19 Jul 2012 · 62011CJ0130
Judgment of the Court (Eighth Chamber) of 12 March 2015. Actavis Group PTC EHF and Actavis UK Ltd v Boehringer Ingelheim Pharma GmbH & Co. KDecision
Recitals 4, 5, 9 and 10 in the preamble to Regulation No 469/2009 are worded as follows: At the moment, the period that elapses between the filing of an application for a patent for a new medicinal product and authorisation to place the …
12 Mar 2015 · 62013CJ0577
Order of the Court (Fourth Chamber) of 25 November 2011. University of Queensland and CSL Ltd v Comptroller General of Patents, Designs and Decision
Recital 1 and recitals 4 to 10 in the preamble to Regulation No 469/2009 are worded as follows: ‘(1) Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal …
25 Nov 2011 · 62010CO0630
Judgment of the Court (Grand Chamber) of 25 July 2018. Teva UK Ltd and Others v Gilead Sciences Inc.Decision
That requirement is in line with the objective of the SPC, which is to re-establish a sufficient period of effective protection of the basic patent by permitting the holder to enjoy an additional period of exclusivity on the expiry of that …
25 Jul 2018 · 62017CJ0121
Judgment of the Court (Fourth Chamber) of 21 March 2019. Abraxis Bioscience LLC v Comptroller General of Patents.Decision
Recitals 3 to 5 and 7 to 10 of Regulation No 469/2009 state as follows: Medicinal products, especially those that are the result of long, costly research will not continue to be developed in the [European Union] and in Europe unless they …
21 Mar 2019 · 62017CJ0443
Judgment of the Court (Third Chamber), 12 December 2013. Georgetown University v Octrooicentrum Nederland.Decision
Recitals 4, 5, 9 and 10 in the preamble to Regulation No 469/2009 read as follows: At the moment, the period that elapses between the filing of an application for a patent for a new medicinal product and authorisation to place the …
12 Dec 2013 · 62012CJ0484
Order of the Court (Fourth Chamber) of 25 November 2011. Daiichi Sankyo Company v Comptroller General of Patents, Designs and Trade Marks.Decision
Recital 1 and recitals 4 to 10 in the preamble to Regulation No 469/2009 are worded as follows: Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products …
25 Nov 2011 · 62011CO0006